Imperial College London

DrDavidMann

Faculty of Natural SciencesDepartment of Life Sciences

Reader in Cell Cycle Control
 
 
 
//

Contact

 

+44 (0)20 7594 5302d.mann

 
 
//

Location

 

605Sir Ernst Chain BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Child:2011:10.1007/s12154-011-0059-5,
author = {Child, ES and Georgiades, SN and Rose, KN and Stafford, VS and Patel, CBK and Steinke, JHG and Mann, DJ and Vilar, R},
doi = {10.1007/s12154-011-0059-5},
journal = {J Chem Biol},
pages = {159--165},
title = {Inhibition of mitogen-activated protein kinase (MAPK) and cyclin-dependent kinase 2 (Cdk2) by platinum(II) phenanthroline complexes.},
url = {http://dx.doi.org/10.1007/s12154-011-0059-5},
volume = {4},
year = {2011}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - UNLABELLED: Inhibition of protein kinases in the fight against disease remains a constant challenge for medicinal chemists, who have screened multitudes of predominantly planar organic scaffolds, natural and synthetic, to identify potent-albeit not always selective-kinase inhibitors. Herein, in an effort to investigate the potential biological utility of metal-based compounds as inhibitors against the cancer-relevant targets mitogen-activated protein kinase and cyclin-dependent kinase 2, we explore various parameters in planar platinum(II) complexes with substituted phenanthroline ligands and aliphatic diamine chelate co-ligands, to identify combinations that yield promising inhibitory activity. The individual ligands' steric requirements as well as their pattern of hydrogen bond donors/acceptors appear to alter inhibitory potency when modulated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12154-011-0059-5) contains supplementary material, which is available to authorized users.
AU - Child,ES
AU - Georgiades,SN
AU - Rose,KN
AU - Stafford,VS
AU - Patel,CBK
AU - Steinke,JHG
AU - Mann,DJ
AU - Vilar,R
DO - 10.1007/s12154-011-0059-5
EP - 165
PY - 2011///
SP - 159
TI - Inhibition of mitogen-activated protein kinase (MAPK) and cyclin-dependent kinase 2 (Cdk2) by platinum(II) phenanthroline complexes.
T2 - J Chem Biol
UR - http://dx.doi.org/10.1007/s12154-011-0059-5
UR - https://www.ncbi.nlm.nih.gov/pubmed/22368708
VL - 4
ER -